TTY Biopharm Co Ltd (4105) — Cash Flow Quality Index
TTY Biopharm Co Ltd (4105) has a Cash Flow Quality Index of 1.48x as of March 2026. Operating cash flow of NT$654.16 Million exceeds net income of NT$443.06 Million, indicating high earnings quality where cash backs reported profits. Explore TTY Biopharm Co Ltd (4105) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
TTY Biopharm Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for TTY Biopharm Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see TTY Biopharm Co Ltd cash flow conversion.
Annual Cash Flow Quality Index for TTY Biopharm Co Ltd (2017–2025)
Year-by-year earnings quality comparison for TTY Biopharm Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | NT$1.76 Billion | NT$1.56 Billion | ▲ +21.4% |
| 2024 | 0.93x | NT$1.35 Billion | NT$1.45 Billion | ▲ +21.7% |
| 2023 | 0.76x | NT$1.09 Billion | NT$1.42 Billion | ▼ -12.9% |
| 2022 | 0.88x | NT$1.24 Billion | NT$1.41 Billion | ▼ -24.1% |
| 2021 | 1.16x | NT$1.26 Billion | NT$1.09 Billion | ▲ +163.7% |
| 2020 | 0.44x | NT$526.35 Million | NT$1.20 Billion | ▼ -67.4% |
| 2019 | 1.34x | NT$1.21 Billion | NT$900.08 Million | ▲ +82.9% |
| 2018 | 0.73x | NT$1.07 Billion | NT$1.46 Billion | ▼ -0.8% |
| 2017 | 0.74x | NT$996.52 Million | NT$1.34 Billion | — |